.jpg)
.png)
All
A recent succession of negative studies— including two randomized, placebocontrolled intervention trials1, 2 and a large genetic association analysis3—calls for a careful re-examination of the approach to HDL-directed therapies. In May 2011 the Atherothrombosis Intervention in Metabolic... more
.page-header { display: none; } .btn-about { margin: 10px; } .v-center { display: flex; align-items: flex-start; justify-content: center; flex-grow: 1; width: 390px; } .flex-row { display... more
I am proud to represent the Northeast Lipid Association (NELA) as president, and in my 30th year of clinical lipidology. At the start of my practice at the the VA Medical Center (VAMC), lovastatin and ATP-1 were just introduced. In these 30 years of practice LDL-C targets have changed from... more
Thank you for your contribution. Your data will be viewed by our staff and posted on our website within 24 hours. <<Go back to the Career Center <<Go back to the Community <<Go back to the Photo Galleries <<Go back to the Mentoring Program
The NLA has released its clinician tear sheet on the 2018 Guideline on the Management of Blood Cholesterol. The tear sheet is an important resource for physicians to quickly and easily reference key points from the 2018 Guideline at a glance. It can be printed or shared electronically for... more
The National Lipid Association (NLA) is pleased to announce that 90 abstracts were accepted for presentation in the poster format for the NLA 2023 Scientific Sessions. Each abstract was reviewed by the NLA Scientific Sessions Abstracts Committee prior to acceptance. Posters were judged on quality... more
Interim results from the ongoing ORION-3 study that examines the long-term safety and efficacy of small interfering RNA (siRNA) therapy drug inclisiran were shared today during the National Lipid Association’s (NLA) 2019 Scientific Sessions late-breaking abstract session.
The 2014 Impact Factors were recently released and the Journal of Clinical Lipidology (JCL) saw another increase — from 3.587 (2013) to 3.904 (2014). The Journal is now ranked 44th out of 254 journals in its category (pharmacology and pharmacy). The Thomson-... more
There is a large population >80 in the U.S., some who have either been advised to or chose to discontinue statin therapy. Randomized clinical trials have typically excluded very elderly subjects or group all elderly into age >65. There are vast differences in this population in terms of... more
The National Committee for Quality Assurance (NCQA) has proposed retiring the use of LDL-C treatment targets in response to the new ACC/AHA Task Force on Practice Guidelines. The NCQA has stated that no studies focus on treatment or titration to a specific LDL-C goal in adults with clinical... more